The notion of a foundation was seen by the board and CEO as an important strategy to protect the growing assets of TGL. In 2013 it was decided to form an independent charitable trust with Deductible Gift Recipient status, and the Therapeutic Guidelines Foundation was established in 2014 as a public ancillary fund with three transfers of money from TGL. The five inuaugural directors of the board, established in 2014, were Marcus Harvey as chair, John Dowden, Richard Kneebone and John Tiller and Mary Hemming. Sue Phillips managed all the establishment arrangements and was formally appointed company secretary in 2013 and general manager in 2016. John Dowden succeeded Marcus Harvey as chair in 2015. The first distribution of a minimum of 4 per cent of the assets after four years of investment will occur during 2018–19.

Since 2015, both TGL and the Foundation have co-sponsored the Developing Countries Program. Outreach to developing countries began in 1994 when, following a visit to Pakistan, Rob Moulds organised for a complete set of guidelines be sent to each medical school there. In 1999 Rob Moulds took copies of superseded editions of guidelines to Fiji when he was professor of medicine at Fiji’s medical school. Also in 1999, at the request of the WHO, Tony Smith assisted Fiji to create its own version of Antibiotic Guidelines based on the TGL model.  Multiple adaptations have been produced of most of the guidelines in many countries in the Pacific Region. Tony Smith and Rob Moulds, as well as Gillian Shenfield, have been responsible for most of these. Fiji has published many of the guidelines titles, some in several editions.

TGL’s generosity and altruism was, by the 2000s, a deeply ingrained characteristic.

Building on these values, TGL established a Visiting Editor Fellowship program in 2007. Open to editors of independent drug and therapeutic information in developing countries, a health professional is selected to visit TGL in Melbourne, observe writing groups, and participate in basic editorial training offered by TGL’s editors. Visiting editors have come from India, Palau, Kiribati, Tonga, Cuba, Argentina, The Philippines and Nigeria.

A special position was created by Therapeutic Guidelines Foundation in 2016 to manage the Developing Countries Program in 2016. Erin Nunan was appointed to the role, and took over responsibility for the Visiting Editor program and other activities for developing countries. Rob Moulds was appointed in 2017 as a part-time medical advisor to the Developing Countries Program. A country-specific app for use on smart phones and tablets that hosts and displays local standard treatment guidelines was developed and launched in 2018.